Plain-English translation of NCT06912646 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Erchonia EVRL, a portable handheld laser device designed to provide temporary relief from foot pain caused by peripheral neuropathy—a condition where nerves in your feet are damaged, often without a clear cause. You would use the device at home on your own feet. The study wants to see whether this treatment can reduce your pain.
Many people with nerve damage in their feet experience chronic pain that is difficult to treat with standard medications alone. This trial is exploring whether this laser device could offer a new way to help manage that pain.
You likely qualify if…
You likely don't qualify if…
You would use the Erchonia EVRL laser device at home on your own feet, following the treatment schedule provided. Throughout the study, you'll track your pain levels and report back to the research team. You'll need to keep your current pain medications stable and avoid starting other treatments for your foot pain during your participation.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
Erchonia Corporation
Enrollment target
~32 participants
Started
May 2025
Primary completion
May 2027
Age range
22 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Travis Sammons
Erchonia Corporation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.